Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NETWORK × ixazomib × Clear all

Phase

Phase 2 2 Phase 1/2 1

Status

Sponsor Class

OTHER 18 INDUSTRY 4 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Radiotherapy 11 Cisplatin 7 Cytarabine 6 Specimen Handling 4 Paclitaxel 4 Lapatinib 4 Fluorouracil 4 Docetaxel 4 Brachytherapy 4 Temozolomide 3 Radiotherapy, Conformal 3 Methotrexate 3 Irinotecan 3 Gemcitabine 3 Dexamethasone 3 Carboplatin 3 Biopsy 3 venetoclax 2 pomalidomide 2 neratinib 2 carfilzomib 2 Radiation 2 Polymerase Chain Reaction 2 Oxaliplatin 2 Leucovorin 2 Immunohistochemistry 2 Idarubicin 2 Etoposide 2 Clofarabine 2 Carmustine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡